| |
| |
|
| Insider
Information: |
Karabelas Argeris N |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
130,211 |
|
|
Indirect Shares
|
3,405,909 |
|
|
| Direct
Value |
$904,788 |
|
|
|
Indirect Value
|
$48,548,603 |
|
|
| Total
Shares |
3,536,120 |
|
|
| Total
Value |
$49,453,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Director |
|
0 |
2004-03-18 |
1,128,770 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
|
0 |
2010-03-12 |
0 |
Premium* |
|
|
Biodelivery Sciences Internation... |
BDSI |
10% Owner |
2009-06-17 |
0 |
2009-07-16 |
0 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2006-11-10 |
0 |
Premium* |
|
|
Rocket Pharmaceuticals |
RCKT |
Director, 10% Owner |
|
0 |
2015-02-23 |
2,277,139 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2022-06-24 |
123,715 |
2016-06-17 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2023-06-02 |
6,496 |
2022-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-30 |
4 |
S |
$6.68 |
$217,918 |
I/I |
(32,640) |
299,074 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-01 |
4 |
S |
$6.76 |
$337,760 |
I/I |
(50,000) |
249,074 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-02 |
4 |
S |
$6.45 |
$42,004 |
I/I |
(6,511) |
242,563 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-06 |
4 |
S |
$6.18 |
$432,502 |
I/I |
(70,000) |
172,563 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-07 |
4 |
S |
$6.12 |
$80,584 |
I/I |
(13,158) |
159,405 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-08 |
4 |
S |
$6.25 |
$1,631 |
I/I |
(261) |
159,144 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-15 |
4 |
S |
$6.00 |
$166,670 |
I/I |
(27,770) |
131,374 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-16 |
4 |
S |
$6.89 |
$905,259 |
I/I |
(131,374) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-10-13 |
4 |
S |
$12.65 |
$3,004,375 |
I/I |
(237,500) |
762,500 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-04 |
4 |
S |
$11.70 |
$1,170,000 |
I/I |
(100,000) |
662,500 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-07 |
4 |
S |
$11.57 |
$1,157,000 |
I/I |
(100,000) |
562,500 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-08 |
4 |
S |
$11.30 |
$298,049 |
I/I |
(26,376) |
536,124 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-09 |
4 |
S |
$11.57 |
$1,240,304 |
I/I |
(107,200) |
428,924 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-14 |
4 |
S |
$11.14 |
$1,448,200 |
I/I |
(130,000) |
298,924 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-15 |
4 |
S |
$11.03 |
$1,091,132 |
I/I |
(98,924) |
200,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2010-03-12 |
4 |
S |
$11.80 |
$2,360,000 |
I/I |
(200,000) |
0 |
0 |
- |
|
66 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
